MarketLens
Sign Up

Biotech IPOs in 2026: A New Wave

4 months ago
SHARE THIS ON:

Biotech IPOs in 2026: A New Wave

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes

Small-cap biotech stocks are rallying as macro and policy headwinds ease, with FDA stabilization and a resurgence in M&A and IPO activity restoring capital flows and investor confidence.
News•3 months ago

Biopharmaceutical company Attovia Therapeutics files for US IPO

Attovia Therapeutics filed for a US IPO on Tuesday, seeking to raise capital through a public listing.
Stock News•3 months ago

Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals

Big Pharma is spending at a pace not seen since 2019 to replace ~$300B in drugs losing patent protection, fueling biotech acquisitions.

Breaking News

View All →

No topics available at the moment

Top Headlines

View More →
Stock News•54 minutes ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•1 hour ago

Why the Market Dipped But Meta Platforms (META) Gained Today

Stock News•1 hour ago

Nvidia in 5 Years: Where the Stock Could Be Headed

Stock News•2 hours ago

UK finance minister Healey to target online marketplaces in tax crackdown, The Times reports

Stock News•2 hours ago

Character.AI owes Google and Big Law firms nearly $7M, court filings show